HOME >> BIOLOGY >> NEWS
Sandia tool speeds up environmental cleanup, reopening of contaminated facilities

LIVERMORE, Calif. - A software-based tool developed by Sandia National Laboratories for managing the collection, visualization, and analysis of environmental sampling data is now available to potential licensing partners.

Sandia's Building Restoration Operations Optimization Model (BROOM) software system was developed to help decision makers - during the planning phase and throughout actual cleanup operations - to speed up reoccupation and return to service of contaminated buildings and facilities. The tool provides an efficient and scientifically defensible approach to planning and executing sampling and cleanup activities. To date, there has been no comprehensive system for handling and assisting with this process.

Sandia is a National Nuclear Security Administration laboratory.

Many potential users, applications

Originally developed for use during cleanup of facilities following a bioterrorism attack, BROOM is easily adapted to other spatial domains where accurate and efficient data tracking, management, optimization, and analysis of samples are needed. Possible users and/or applications of BROOM include:

  • Environmental cleanup (including Superfund sites)
  • Remediation companies
  • Industrial hygiene
  • Forensics/crime units
  • Incident characterization
  • Decontamination contractors
  • Health agencies
  • Airports, subways
  • Government buildings
  • Ports of entry
  • Water utilities
  • Gas and electric utilities
  • Chemical plants
  • Other critical infrastructure facilities

Cost, efficiency savings could reach into multi-millions of dollars

The cost to shut down public facilities, plants, or businesses can be enormous. According to Business Week, costs of the 23-day closure of Ronald Reagan National Airport in Washington, DC after the 9/11 attacks have been estimated at $330 million per day
'"/>

Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
7-Jun-2006


Page: 1 2 3 4

Related biology news :

1. Sandia researchers take new approach to studying how cells respond to pathogens
2. Sandia research to focus on early detection of harmful algal blooms
3. Sandia researchers discover way to see how a drug attaches to a cell
4. Sandia National Laboratories and Monsanto Company announce cooperative research agreement
5. Two Sandia microChemLab technologies soon to be checking for toxins in the nations water supplies
6. Sandia researchers to study techniques for arsenic removal from drinking water
7. MIT: Engineered yeast speeds ethanol production
8. Engineered yeast speeds ethanol production
9. In young rats, researchers find a reaction to spinal cord injury that speeds recovery
10. Gene design program from Johns Hopkins simplifies, automates and speeds design of artificial genes
11. U. Iowa finding speeds up immunization booster schedule

Post Your Comments:
(Date:10/15/2014)... is a non-traditional biophysics textbook and it describes how ... journey of discovery into biological systems and provides an ... It is about how our genes make proteins that ... of cells in an organism. It quantifies the principles ... can be found on both large and small scales. ...
(Date:10/15/2014)... Alt will be awarded the 44th Rosenstiel Award for ... his pioneering research exploring the mechanisms of genomic instability ... cells. Alt is the second alumnus to win the ... Prize in 2003. , Alt is the Charles A. ... Harvard Medical School and an investigator at the Howard ...
(Date:10/14/2014)... N.Y. – Scientists have sequenced the house fly genome ... one might expect from an insect that thrives in ... published Oct. 14 in the journal Genome Biology ... biology and of how flies quickly adapt to resist ... Adult house flies (Musca domestica) carry and transmit more ...
Breaking Biology News(10 mins):New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2
(Date:10/22/2014)... , Oct. 22, 2014   Synthetic Biologics, ... novel pathogen-specific therapies for serious infections and diseases, announced ... issued a Notice of Allowance for a composition of ... C. difficile program, SYN-004. This is Synthetic ... in the U.S. and adds to the Company,s extensive ...
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... 2014 Asterias Biotherapeutics, Inc. (NYSE MKT: ... a Notice of Grant Award (NGA) with the ... 1, 2014.  The NGA provides for the immediate ... of additional grant funds pursuant to the previously ... development of Asterias, product, AST-OPC1. The grant provides ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech ... company tackling big healthcare problems, announced today the ... round, with participation from Invesco Perpetual, a $120 ... used to drive PureTech,s existing pipeline forward and ... "PureTech has the scientific creativity to really go ...
Breaking Biology Technology:Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
Cached News: